Stay updated with breaking news from Aicuris. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Larry Edwards brings more than two decades of experience in executive and commercial leadership roles in the anti-infective space at both biotechnology and large pharmaceutical companiesAiCuris establishes ....
The AiCubator program was launched to provide first-hand support to fuel early research projects of young start-ups and academic teams that have the potential to become the next generation of resistance ....
New project started to jointly develop Artilysin(R)s as innovative novel treatment option for infected, chronic wounds such as diabetic foot infections, the most common complication of diabetes mellitusExpansion ....
AiCubator was launched by AiCuris in 2020 to provide long-term support for early but promising research projects in the field of anti-infectivesSecond round application period open through December 31 ....